Buscar
01/01/2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
Kuster S., Jordan S., Elhai M., Held U., Steigmiller K., Bruni C., Cacciapaglia F., Vettori S., Siegert E., Rednic S., Codullo V., Airo P., Braun-Moscovici Y., Hunzelmann N., Joao Salvador M., Riccieri V., Gheorghiu A.-M., Alegre Sancho J.J., Romanowska-Prochnicka K., Castellví I., Kötter I., Truchetet M.-E., López-Longo F.J., Novikov P.I., Giollo A., Shirai Y., Belloli L., Zanatta E., Hachulla E., Smith V., Denton C., Ionescu R.M., Schmeiser T., Distler J.H.W., Gabrielli A., Hoffmann-Vold A.-M., Kuwana M., Allanore Y., Distler O.. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002477. PMID:36328401. IF:6.200(Q1/2D).
01/01/2022
How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop
Balsa A., González-Álvaro I., Sanmartí R., Corominas H.. How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2021.08.002. PMID:34489191. IF:(Q/D).
01/01/2022
SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Narváez J., Díaz del Campo Fontecha P., Brito García N., Bonilla G., Aburto M., Castellví I., Cano-Jiménez E., Mena-Vázquez N., Nieto M.A., Ortiz A.M., Valenzuela C., Abad Hernández M.Á., Castrejón I., Correyero Plaza M., Francisco Hernández F.M., Hernández Hernández M.V., Rodríquez Portal J.A.. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. IF:(Q/D).
01/01/2022
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis
Rodríguez Portal J.A., Brito García N., Díaz del Campo Fontecha P., Valenzuela C., Ortiz A.M., Nieto M.A., Mena-Vázquez N., Cano-Jiménez E., Castellví I., Aburto M., Bonilla G., Hernández Hernández M.V., Hernández F.M.F., Correyero Plaza M., Castrejón I., Abad Hernández M.Á., Narváez J.. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8)DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. IF:(Q/D).
01/01/2022
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)
Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8). Rheumatology and Therapy. 2022; 9(4)DOI:10.1007/s40744-022-00463-8. PMID:35653064. IF:3.800(Q3/6D).
01/01/2022
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Cobo-Ibáñez T., Sánchez-Piedra C., Nuño-Nuño L., Castellví I., Carrión-Barberà I., Romero-Bueno F., Narváez J., Trallero-Araguás E., Tomero E., Ruiz-Lucea M.E., Larena C., Carrasco Cubero C., Jovaní V., Barbadillo C., Sivera F., Belzunegui J., Pérez Gómez A., Gómez Gómez A., Delgado-Frías E., Pego-Reigosa J.M., Joven B., Ibáñez M., Martínez-González O., Ruiz-Román A., Camins J., Ortega-Castro R., Trenor Larra P., Rodríguez López M., Freire M., Alcocer P., Holgado S., Rúa-Figueroa I., Lozano N., Martínez-Barrio J.. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5)DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. IF:(Q/D).
01/01/2022
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Pinto Tasende J.A., Bethencourt Baute J.J., Joven Ibáñez B., Toniolo E., Ramírez J., Pruenza García-Hinojosa C.. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3.900(Q2/4D).
01/01/2022
Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria
Mir-Perelló C., López B.M., Pérez B.S., Torrent R.B., Fernández M.I.G., Corbeto M.L., Gil J.G., Zavala R.G.. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94)DOI:. PMID:. IF:(Q/D).